Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapy

被引:0
|
作者
Hardev Pandha
Jonathan Eaton
Rebecca Greenhalgh
Diane Soars
Angus Dalgleish
机构
[1] St George's Hospital Medical School,Department of Oncology
[2] Cranmer Terrace,undefined
来源
Cancer Gene Therapy | 2005年 / 12卷
关键词
HSV-tk; cancer vaccine;
D O I
暂无
中图分类号
学科分类号
摘要
Whole cell cancer vaccines are currently under clinical evaluation. Their immunogenicity may depend on the mode of death of the vaccine cells prior to uptake by professional antigen-presenting cells and crosspriming of T cells. Destruction of tumor in vivo by genetic prodrug activation therapy leads to a marked local and systemic immune response, local T-cell infiltration and the establishment of T-cell memory. We postulated that this immunostimulation may be due to induction of danger signals and the inherent immunogenicity of products of HSVtk/ganciclovir kill. Using established models of murine prostate cancer, we have evaluated the efficacy of anti-tumor vaccines comprising irradiated allogeneic or autologous whole cells expressing HSVtK, which are first killed in vitro by prodrug activation using ganciclovir. HSVtk/ganciclovir-induced cell kill was through the induction of apoptosis. The vaccine was found to be effective in both models and superior to traditional irradiated whole tumor cells even after single doses. Protection against tumor challenge was associated with marked proliferative and Th1 cytokine responses. This approach would be applicable clinically in terms of ease of vaccine production, safety, storage and avoidance of potential toxicities of in vivo gene transfer.
引用
收藏
页码:572 / 578
页数:6
相关论文
共 50 条
  • [41] Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
    Simon J Hall
    Steven E Mutchnik
    Guang Yang
    Terry L Timme
    Yasutomo Nasu
    Chris H Bangma
    Savio L C Woo
    Mohammed Shaker
    Timothy C Thompson
    Cancer Gene Therapy, 1999, 6 : 54 - 63
  • [42] Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene
    Yang, L
    Hwang, R
    Chiang, YW
    Gordon, EM
    Anderson, WF
    Parekh, D
    CLINICAL CANCER RESEARCH, 1998, 4 (03) : 731 - 741
  • [43] Effect of gene therapy with the herpes simplex virus-thymidine kinase gene on hepatic metastasis in murine colon cancer
    Shuji Hayashi
    Nobuhiko Emi
    Itsuo Yokoyama
    Kazuharu Uchida
    Hiroshi Takagi
    Surgery Today, 1997, 27 : 40 - 43
  • [44] Intercellular communication mediates the bystander effect during herpes simplex thymidine kinase/ganciclovir-based gene therapy of human gastrointestinal tumor cells
    Yang, L
    Chiang, YW
    Lenz, HJ
    Danenberg, KD
    Spears, CP
    Gordon, EM
    Anderson, WF
    Parekh, D
    HUMAN GENE THERAPY, 1998, 9 (05) : 719 - 728
  • [45] Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase
    Hattori, Y
    Maitani, Y
    CANCER GENE THERAPY, 2005, 12 (10) : 796 - 809
  • [46] Experimental gene therapy for prostate cancer: Treatment of mouse prostate cancer with adenovirus mediated interleukin-12 gene transduction alone and in combination with herpes simplex virus thymidine kinase gene transduction and ganciclovir therapy
    Nasu, Y
    Bangma, CH
    Hull, GW
    Hu, JC
    Wang, JX
    Timme, TL
    Thompson, TC
    JOURNAL OF UROLOGY, 1998, 159 (05): : 1 - 1
  • [47] Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase
    Yoshiyuki Hattori
    Yoshie Maitani
    Cancer Gene Therapy, 2005, 12 : 796 - 809
  • [48] Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound
    Aoi, Atsuko
    Watanabe, Yukiko
    Mori, Shiro
    Takahashi, Masahiko
    Vassaux, Georges
    Kodama, Tetsuya
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2008, 34 (03): : 425 - 434
  • [49] Gene therapy of metastatic pancreas cancer with intraperitoneal injections of concentrated retroviral herpes simplex thymidine kinase vector supernatant and ganciclovir
    Yang, L
    Hwang, R
    Pandit, L
    Gordon, EM
    Anderson, WF
    Parekh, D
    ANNALS OF SURGERY, 1996, 224 (03) : 405 - 414
  • [50] Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex viruus thymidine kinase ganciclovir paradigm
    Rainov, NG
    Kramm, CM
    AboodyGuterman, K
    Chase, M
    Ueki, K
    Louis, DN
    Harsh, GR
    Chiocca, A
    Breakefield, XO
    CANCER GENE THERAPY, 1996, 3 (02) : 99 - 106